Bin Cheng Selected Research

Infections

1/2022	Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors.
1/2022	CCDC88A/GIV promotes HBV replication and progeny secretion via enhancing endosomal trafficking and blocking autophagic degradation.
1/2022	Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis.
1/2021	Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity.
1/2021	Microbial Distribution and Antibiotic Susceptibility of Bloodstream Infections in Different Intensive Care Units.
10/2010	Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.
7/2008	Hand hygiene among general practice dentists: a survey of knowledge, attitudes and practices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bin Cheng Research Topics

Disease

74	Neoplasms (Cancer) 01/2024 - 06/2004
41	Squamous Cell Carcinoma of Head and Neck 09/2023 - 08/2004
27	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2002
21	Carcinogenesis 10/2023 - 04/2004
18	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2006
15	Inflammation (Inflammations) 04/2024 - 10/2010
13	Oral Lichen Planus 10/2023 - 03/2005
8	Wounds and Injuries (Trauma) 04/2024 - 01/2011
8	Heart Failure 11/2022 - 05/2012
7	Infections 01/2022 - 07/2008
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2019 - 04/2003
6	Hypoxia (Hypoxemia) 10/2023 - 01/2008
6	Carcinoma (Carcinomatosis) 01/2022 - 04/2003
6	Pain (Aches) 01/2022 - 03/2012
5	Periodontitis 01/2024 - 06/2012
5	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023 - 01/2008
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2017
5	Spinal Cord Ischemia 08/2019 - 03/2006
5	Left Ventricular Dysfunction 02/2014 - 01/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 02/2021
4	Atherosclerosis 09/2023 - 10/2010
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 01/2021
4	Hypertension (High Blood Pressure) 01/2021 - 08/2015
4	Reperfusion Injury 08/2019 - 06/2006
4	Mouth Neoplasms (Oral Cancer) 04/2018 - 07/2013
3	Cognitive Dysfunction 01/2024 - 01/2016
3	Liver Neoplasms (Liver Cancer) 01/2024 - 02/2016
3	Insulin Resistance 11/2023 - 09/2016
3	Fibrosis (Cirrhosis) 09/2023 - 12/2018
3	Pneumonia (Pneumonitis) 09/2023 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 02/2019
3	Non-alcoholic Fatty Liver Disease 06/2022 - 09/2016
3	Yang Deficiency (Xu, Yang) 01/2022 - 01/2012
3	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 01/2018
3	Lymphoma (Lymphomas) 01/2018 - 04/2011
3	Ischemia 04/2011 - 06/2006
2	Hemorrhage 05/2024 - 09/2015
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2023
2	Fatigue 04/2024 - 01/2020
2	Sleep Deprivation 11/2023 - 10/2023
2	Rubella (German Measles) 09/2023 - 11/2020
2	Sepsis (Septicemia) 01/2023 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 11/2022

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2003
17	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2007
15	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
9	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 09/2016
9	CytokinesIBA 09/2023 - 03/2005
8	LigandsIBA 10/2023 - 04/2011
7	LipidsIBA 01/2024 - 01/2021
7	Long Noncoding RNAIBA 01/2024 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2009
6	oxidized low density lipoproteinIBA 10/2023 - 01/2021
6	hepatitis B virus X proteinIBA 10/2014 - 12/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2018
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 03/2005
5	InflammasomesIBA 01/2024 - 11/2020
5	Glutamine (L-Glutamine)FDA Link 10/2023 - 01/2020
5	Interleukin-6 (Interleukin 6)IBA 02/2023 - 03/2005
5	CateninsIBA 04/2022 - 02/2016
4	Small Interfering RNA (siRNA)IBA 01/2024 - 02/2014
4	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 10/2023 - 01/2021
4	DiterpenesIBA 09/2023 - 04/2018
4	Indicators and Reagents (Reagents)IBA 01/2022 - 05/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2002
4	LipopolysaccharidesIBA 10/2021 - 06/2012
4	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 01/2019 - 02/2007
4	salicylhydroxamic acid (SHAM)IBA 01/2018 - 06/2006
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 07/2011
4	DNA Repair EnzymesIBA 02/2010 - 06/2004
3	Silicon Dioxide (Silica)FDA LinkGeneric 09/2023 - 04/2014
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 01/2021
3	Chemokine ReceptorsIBA 01/2022 - 04/2011
3	ChemokinesIBA 01/2022 - 04/2011
3	heparanaseIBA 02/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2009
3	Receptor for Advanced Glycation End ProductsIBA 01/2019 - 08/2010
3	CC ChemokinesIBA 02/2018 - 03/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 12/2014
3	NF-kappa B (NF-kB)IBA 01/2007 - 03/2005
2	HydrogelsIBA 04/2024 - 11/2023
2	p38 Mitogen-Activated Protein KinasesIBA 02/2024 - 02/2021
2	CholesterolIBA 10/2023 - 04/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 01/2021
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2023 - 01/2022
2	AbietanesIBA 09/2023 - 11/2020
2	Glucuronic Acid (Glucuronate)IBA 03/2023 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2020
2	6-methyladenineIBA 01/2023 - 11/2022
2	Apolipoproteins B (ApoB)IBA 11/2022 - 01/2021
2	epimedii flavoneIBA 11/2022 - 03/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 10/2021

Therapy/Procedure

26	Therapeutics 11/2023 - 07/2006
10	Immunotherapy 01/2023 - 01/2019
8	Cardiac Resynchronization Therapy 10/2015 - 05/2012
7	Drug Therapy (Chemotherapy) 07/2023 - 08/2015
5	Radiotherapy 05/2023 - 01/2008
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2014 - 05/2012
3	Length of Stay 04/2024 - 10/2019